Impaired liver cytochrome P450 2C11 activity after dual antiplatelet therapy with aspirin and clopidogrel in rats

References

• Arya V, Mahajan P, Saraf A, et al. (2015). Association of CYP2C19, CYP3A5 and GPIIb/IIIa gene polymorphisms with aspirin and clopidogrel resistance in a cohort of Indian patients with coronary artery disease. Int J Lab Hematol 37:809–18
   PubMed Web of Science ®Google Scholar
• Bahrami G, Mohammadi B, Sisakhtnezhad S. (2008). High performance liquid chromatographic determination of inactive carboxylic acid metabolite of clopidogrel in human serum: application to a bioequivalence study. J Chromatogr B 864:168–72
   PubMed Web of Science ®Google Scholar
• Benedito MA. (1997). Fluorimetric determination of tissue distribution and differences between the activity of aspirin esterases I and II in mice and rats. J Pharm Pharmacol 49:273–6
   PubMed Web of Science ®Google Scholar
• Bhatt DL, Fox KA, Hacke W, et al. (2006). Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354:1706–17
   PubMed Web of Science ®Google Scholar
• Cerletti C, Dell’elba G, Manarini S, et al. (2013). Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes. Clin Pharmacokinet 42:1059–70
   Web of Science ®Google Scholar
• Chen F, Yang Y, Fang C, et al. (2015). Effect of fluvoxamine on the pharmacokinetics and pharmacodynamics of clopidogrel in rats. Xenobiotica 45:1122–8
   PubMed Web of Science ®Google Scholar
• Chen X, Jin J, Chen Y, et al. (2015). Effect of scutellarin on the metabolism and pharmacokinetics of clopidogrel in rats. Biopharm Drug Dispos 36:64–8
   PubMed Web of Science ®Google Scholar
• Chen XP, Tan ZR, Huang SL, et al. (2003). Isozyme-specific induction of low-dose aspirin on cytochrome P450 in healthy subjects. Clin Pharmacol Ther 73:264–71
   PubMed Web of Science ®Google Scholar
• Chhonker YS, Pandey CP, Chandasana H, et al. (2016). Simultaneous quantitation of acetylsalicylic acid and clopidogrel along with their metabolites in human plasma using liquid chromatography tandem mass spectrometry. Biomed Chromatogr 30:466–73
   PubMed Web of Science ®Google Scholar
• Deng Y, Mo YF, Chen XM, et al. (2016). Effect of Ginkgo Biloba extract on the pharmacokinetics and metabolism of clopidogrel in rats. Phytother Res 30:1886–92
   PubMed Web of Science ®Google Scholar
• Farid NA, Kurihara A, Wrighton SA. (2010). Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans. J Clin Pharmacol 50:126–42
   PubMed Web of Science ®Google Scholar
• Glanemann C, Loos A, Gorret N, et al. (2003). Disparity between changes in mRNA abundance and enzyme activity in Corynebacterium glutamicum: implications for DNA microarray analysis. Appl Microbiol Biotechnol 61:61–8
   PubMed Web of Science ®Google Scholar
• Gurbel PA, Udaya ST. (2010). Combination antithrombotic therapies. Circulation 121:569–83
   PubMed Web of Science ®Google Scholar
• Hill JR. (2004). In vitro drug metabolism using liver microsomes. Curr Protoc Pharmacol 23:7.8:7.8.1–7.8.11
   Google Scholar
• Jung JA, Kim TE, Kim JR, et al. (2013). The pharmacokinetics and safety of a fixed-dose combination of acetylsalicylic acid and clopidogrel compared with the concurrent administration of acetylsalicylic acid and clopidogrel in healthy subjects: a randomized, open-label, 2-sequence, 2-period, single-dose crossover study. Clin Ther 35:985–94
   PubMed Web of Science ®Google Scholar
• Jung KH, Chu K, Lee ST, et al. (2011). Prolonged use of aspirin alters human and rat intestinal cells and thereby limits the absorption of clopidogrel. Clin Pharmacol Ther 90:612–19
   PubMed Web of Science ®Google Scholar
• Kernan WN, Ovbiagele B, Black HR, et al. (2014). Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 45:2160–236
   PubMed Web of Science ®Google Scholar
• Lee JH, Shin YJ, Kim HJ, et al. (2011). Danshen extract does not alter pharmacokinetics of docetaxel and clopidogrel, reflecting its negligible potential in P-glycoprotein- and cytochrome P4503A-mediated herb–drug interactions. Int J Pharm 410:68–74
   PubMed Web of Science ®Google Scholar
• Lee JH, Shin YJ, Oh JH, et al. (2012). Pharmacokinetic interactions of clopidogrel with quercetin, telmisartan, and cyclosporine A in rats and dogs. Arch Pharm Res 35:1831–7
   PubMed Web of Science ®Google Scholar
• Levine GN, Bates ER, Bittl JA, et al. (2016). 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol 68:1082–115
   PubMed Web of Science ®Google Scholar
• Li W, Liu Y, He Y, et al. (2008). Characterization of triptolide hydroxylation by cytochrome P450 in human and rat liver microsomes. Xenobiotica 38:1551–65
   PubMed Web of Science ®Google Scholar
• Liu A, Zhao L, Yu S, et al. (2015). Pre-treatment with puerarin affects pharmacokinetics of warfarin, but not clopidogrel, in experimental rats. Chin J Nat Med 13:257–63
   PubMed Web of Science ®Google Scholar
• Meade EA, Smith WL, Dewitt DL. (1993). Differential inhibition of prostaglandin endoperoxide synthase (Cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 268:6610–4
   PubMed Web of Science ®Google Scholar
• Mills DC, Puri R, Hu CJ, et al. (1992). Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Arterioscl Throm 12:430–6
   PubMed Web of Science ®Google Scholar
• Monograph AP, Glucobay A. (2012). Aspirin. Bayer Inc. Consumer Care
   Google Scholar
• Monograph P. (2012). Plavix®. Sanofi-Aventis Canada Inc
   Google Scholar
• Nishiya Y, Hagihara K, Kurihara A, et al. (2009). Comparison of mechanism-based inhibition of human cytochrome P450 2C19 by ticlopidine, clopidogrel, and prasugrel. Xenobiotica 39:836–43
   PubMed Web of Science ®Google Scholar
• Oh J, Shin D, Lim KS, et al. (2014). Aspirin decreases systemic exposure to clopidogrel through modulation of P-glycoprotein but does not alter its antithrombotic activity. Clin Pharmacol Ther 95:608–16
   PubMed Web of Science ®Google Scholar
• Ohtsuki S, Schaefer O, Kawakami H, et al. (2011). Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities. Drug Metab Dispos 40:83–92
   PubMed Web of Science ®Google Scholar
• Pascal LE, True LD, Campbell DS, et al. (2008). Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate. BMC Genomics 9:246–58
   PubMed Web of Science ®Google Scholar
• Reagan-Shaw S, Nihal M, Ahmad N. (2008). Dose translation from animal to human studies revisited. FASEB J 22:659–61
   PubMed Web of Science ®Google Scholar
• Reist M, Roy-de Vos M, Montseny JP, et al. (2000). Very slow chiral inversion of clopidogrel in rats: a pharmacokinetic and mechanistic investigation. Drug Metab Dispos 28:1405–10
   PubMed Web of Science ®Google Scholar
• Rodríguez-Antona C, Donato MT, Pareja E, et al. (2001). Cytochrome P-450 mRNA expression in human liver and its relationship with enzyme activity. Arch Biochem Biophys 393:308–15
   PubMed Web of Science ®Google Scholar
• Savi P, Herbert JM, Pflieger AM, et al. (1992). Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine CLP. Biochem Pharmacol 44:527–32
   PubMed Web of Science ®Google Scholar
• Savi P, Labouret C, Delesque N, et al. (2001). P2y(12), a new platelet ADP receptor, target of clopidogrel. Biochem Biophys Res Commun 283:379–83
   PubMed Web of Science ®Google Scholar
• Schrör K. (1997). Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Semin Thromb Hemost 23:349–56
   PubMed Web of Science ®Google Scholar
• Tian Z, Pang H, Du S, et al. (2017). Effect of Panax notoginseng saponins on the pharmacokinetics of aspirin in rats. J Chromatogr B Anal Technol Biomed Life Sci 1040:136–43
   PubMed Web of Science ®Google Scholar
• US FDA CDER. Available at: http://www.fda.gov/cder/guidance/index.htm
   Google Scholar
• US FDA. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM386366.pdf
   Google Scholar
• Vargas Loza AM, Sánchez Montes De Oca EI, Posadas Del Rio FA. (1997). Sex differences in the enzymatic hydrolysis of acetylsalicylic acid by microsomes from various rat tissues. J Appl Toxicol 17:347–51
   PubMed Web of Science ®Google Scholar
• Wang Y, Pan Y, Zhao X, et al. (2015). Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE) Trial: one-year outcomes. Circulation 132:40–6
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang Y, Zhao X, et al. (2013). Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 369:11–9
   PubMed Web of Science ®Google Scholar
• Watanabe M, Kumai T, Matsumoto N, et al. (2004). Expression of CYP3A4 mRNA is correlated with CYP3A4 protein level and metabolic activity in human liver. J Pharmacol Sci 94:459–62
   PubMed Web of Science ®Google Scholar
• Wientjes MG, Levy G. (1988). Nonlinear pharmacokinetics of aspirin in rats. J Pharmacol Exp Ther 245:809–15
   PubMed Web of Science ®Google Scholar
• Wu MT, Shaw LH, Wu YT, et al. (2013). Interaction of acupuncture and electroacupuncture on the pharmacokinetics of aspirin and the effect of brain blood flow in rats. Evid-Based Compl Alt Med 6:1–9
   Google Scholar
• Zhang Z, Ge B, Zhou L, et al. (2014). Induction of liver cytochrome P450s by Danshen-Gegen formula is the leading cause for its pharmacokinetic interactions with warfarin. J Ethnopharmacol 154:672–86
   PubMed Web of Science ®Google Scholar
• Zhao L, Lou Y. (1995). In vitro studies on omeprazole metabolism in rat liver microsomes. Acta Pharm Sin 30:248–53
   Google Scholar
• Zhou L, Wang S, Zhang Z, et al. (2012). Pharmacokinetic and pharmacodynamic interaction of Danshen-Gegen extract with warfarin and aspirin. J Ethnopharmacol 143:648–55
   PubMed Web of Science ®Google Scholar